From the Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden ; Lymphatic Development Laboratory, Cancer Research UK London Research Institute, London, United Kingdom ; Howard Hughes Medical Institute, The Jackson Laboratory, Bar Harbor, ME ; Wihuri Research Institute, Translational Cancer Biology Program, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland ; Biotechnology Programme, Spanish National Cancer Research Centre, Madrid, Spain . Correspondence to Taija Makinen, Department of Immunology, Genetics, and Pathology, Uppsala University, Dag HammarskjA ldsvA g 20, 75185 Uppsala, Sweden.